chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I feel pretty bad body aches; I've been having a fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 13-Sep-2021 and was forwarded to Moderna on 13-Sep-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (I feel pretty bad body aches) and PYREXIA (I've been having a fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (I feel pretty bad body aches) and PYREXIA (I've been having a fever). At the time of the report, MYALGIA (I feel pretty bad body aches) and PYREXIA (I've been having a fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment medication was reported.
Day 1: Feel sick to stomach (after 2 1/2 hours) right arm swollen (whole arm) pain no sleep at night. Day 2 Left arm was red/swollen/pain/sick to stomach right arm still swollen. Day 3 right arm still swollen/pain. Day 8 feel better no more swelling no more pain back to normal.
Headache, chills, nausea, body aches, high fever, lack of appetite and tired. Treated with ibuprofen and NyQuil. Everything lasted about 24 hours, tiredness still lingering day 2
Chills, body aches, joint pain, headache, nausea, fever starting 1 1/2 hours after vaccination and lasting 2-3 days.  Headache has continued off and on to date.
This case was reported by a healthcare professional and described the occurrence of general back pain in a 22-year-old female subject who was vaccinated with ENGERIX B (GlaxoSmithKline), and seasonal influenza vaccine (non-gsk). There were no concurrent medications. On 3 November 2009 between 09:30 and 10:00 am, the subject received 1st dose of ENGERIX B (1 ml, unknown, left arm). On 3 November 2009 the subject received 1st dose of Seasonal influenza vaccine (Non-GSK, Sanofi Pasteur, unknown). On 3 November 2009 in the evening, less than one day after vaccination with ENGERIX B and Seasonal influenza vaccine (Non-GSK), the subject experienced general aches and pains in the low back and legs, chills, night sweat, and coughed and vomited mucous. The healthcare professional considered the events were disabling. At the time of reporting the events were unresolved. On 05 November 2009, the nurse reported there were three other subjects with the types of aches and pains. The immunization series was discontinued. This makes four out of 10 people with this same lot number of hepatitis B vaccine. See case IDs A0815878A, A0815433A, and A0815453A for more details on the other three subjects). Follow up information was received on 06 November 2009. The health care professional wanted to file a QA (quality assurance) report. She received 20 ENGERIX vials in October 2009. She had distributed six of these vials and four subjects developed severe reactions to the vaccinations. She felt that these vaccines had a quality issue and she will not use the rest of the vials from this lot/shipment. She had the vaccines to return to GSK for investigation.
Felt dizzy first day and pretty much slept it off. On the third day vertigo kicked in. I had vertigo one time many years ago and recognized it. I tested myself with what they taught me when I had it in the past. Maybe this is what people are calling "feeling dizzy" or "brain fog", but for sure it was vertigo, which definitely gave me brain fog. I couldn't think clearly for many days.  Had it for 3 full days, starting 3 days after the shot. Other than that, zero symptoms.
high fevers, lethargy, vomiting; started 6-8 hrs p/vax; admitted for observation;
Expired vaccine and product storage error.; there was a confusion between the expiration date printed in the carton and the expiration date when the QR code is scanned; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine and product storage error.) and PRODUCT LABEL CONFUSION (there was a confusion between the expiration date printed in the carton and the expiration date when the QR code is scanned) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jun-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine and product storage error.) and PRODUCT LABEL CONFUSION (there was a confusion between the expiration date printed in the carton and the expiration date when the QR code is scanned). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine and product storage error.) and PRODUCT LABEL CONFUSION (there was a confusion between the expiration date printed in the carton and the expiration date when the QR code is scanned) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No Treatment Medication reported.  On 18 Nov 2021 the vaccine was stored in refrigerator.
Severe body aches; Fatigue; Nerve pain that went on for about 8 months. Has recently diminished to tolerable levels.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 11Nov2021 as dose 3 (booster), single (Lot number: FF2593) at the age of 64 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Arthritis" (unspecified if ongoing); "Fibromyalgia" (unspecified if ongoing); "Known allergies: Latex" (unspecified if ongoing). Concomitant medication(s) included: VITAMIN D [COLECALCIFEROL]. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: En6200, Location of injection: Arm Left), administration date: 04Mar2022, when the patient was 63-year-old, for COVID-19 immunization; BNT162b2 (Dose Number: 2, Batch/Lot No: En6200, Location of injection: Arm Left), administration date: 25Mar2021, when the patient was 63-year-old, for COVID-19 immunization. The following information was reported: FATIGUE (non-serious) with onset 12Nov2021, outcome "recovering"; NEURALGIA (non-serious) with onset 12Nov2021, outcome "recovering", described as "Nerve pain that went on for about 8 months. Has recently diminished to tolerable levels."; PAIN (non-serious) with onset 12Nov2021, outcome "recovering", described as "Severe body aches". The events "severe body aches", "fatigue" and "nerve pain that went on for about 8 months. has recently diminished to tolerable levels." required physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain, fatigue, neuralgia.  Additional information: Facility where the most recent COVID-19 vaccine was administered was doctor's office/urgent care. Patient did not receive any other vaccine in four weeks. Patient received Multi vitamin in two weeks. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since vaccination, patient has not been tested for COVID-19. It was reported that patient experienced severe body aches, fatigue, nerve pain that went on for about 8 months. Has recently diminished to tolerable levels.
contracted covid after getting the vaccine; contracted covid after getting the vaccine; This is a spontaneous report from a Pfizer-sponsored program. A contactable physician reported similar events for 4 patients. This is 1st of 4 reports. A 46-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: Unknown, does not have lot number to provide) via an unspecified route of administration on 24Dec2020 at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient contracted COVID after getting the vaccine on 01Jan2021. The outcome of the events was unknown.  Information on the Lot/Batch number has been requested; Sender's Comments: The association between the event lack of effect (contracted COVID) with BNT162b2 can not be completely excluded.,Linked Report(s) : US-PFIZER INC-2021003894 same reporter/drug/event, different patient;US-PFIZER INC-2021003893 same reporter/drug/event, different patient;US-PFIZER INC-2021003895 same reporter/drug/event, different patient
I experienced after my J&J vaccine, tinnitus worse, R>L. I got skin rashes, eczema on my face and scalp and nose bleeds.  I also experienced chills,, fatigue for the first two days.    I still continue with skin rashes, eczema on my face and scalp and nose bleeds.    I have been seeing my ENT and PCP at this point since I still continue with symptoms.
3 raised papules - 2 scabbed around shot site. no vesicles, no pustules, localized, no infection. Keep clean, Neosporin and Bandaid
COVID-19 symptoms started 06/20/2022; tested positive 06/21/22. Symptoms were fever, chills, headache, coughing, nasal congestion, and fatigue. The fever and aches lasted 2 days, but the fatigue, coughing, and sinus congestion continued until I went to the doctor on 06/29/22 and they checked my lungs (clear) and then gave me 3 prescriptions. Slowly each day I've been feeling better but I still have lingering cough.
On 1/4/2020 at roughly 07:00 PM, a dull ache started in my right arm where the vaccine was injected, it radiated from my right shoulder, to my right shoulder blade. My arm felt very heavy. There was also a small hard lump beginning to form with a little heat at the injection site. I had difficulty sleeping due to the aching pain. On 1/5/2020, I woke up at 06:30 AM, the lump had grown in size, and was much more red and hot to the touch, in an oval shape. By roughly 11:30 AM same day, it began to itch, I had checked it and the lump had raised significantly. Hot to the touch. The dull ache had begun radiating into my right armpit as well as down to my right elbow. By 06:00 PM, same day, the aching had continued,  the lump was still very raised, itchy, red, and hot. It looked like a large hive. By 06:30 AM on 1/6/2020, the dull ache had mostly subsided, my shoulder blade still felt uncomfortable. The itching continued. The redness spread in size, however the swelling of the lump had gone down slightly. By 06:30 AM on 1/7/2020, the lump had mostly gone down in size significantly, the dull ache had subsided completely, the redness had gone away. By 1/8/2020, 10:00 PM, the lump and swelling are gone, no ache, no itch, still a slight discoloration where lump was.
No additional AEs were reported; The physician reported that a patient received improperly stored vaccine.; This spontaneous report was received from a physician and refers to a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported.   On 14-SEP-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U024221, expiration date: 04-AUG-2023, administered for prophylaxis (strength, dose and route of administration were not provided) (product storage error). Administered dose of vaccine underwent temperature excursion: -12.5 Celsius degrees for 1 hour. None previous temperature excursion was noted. No additional adverse event was reported (no adverse event).
Skin rash started in lower back, looked like a bug bite (hives/welts) - started to feel on chest & breast. Completely all over back + stomach and now on arms. Itchy all over body. Burning sensation - feels like eczema. Dry. Peeling. As big as mosquito bites. Still occurring.
This spontaneous report as received from a pharmacist refers to a 61 year old male patient. The patient had no drug reaction/allergies. On 20-AUG-2013 the patient was vaccinated with a dose of ZOSTAVAX (lot # J001694, Exp date: 08-MAY-2014) 0.65 ml, subcutaneously. Concomitant therapies included ADVAIR, SIMCOR, and metoprolol. ON 21-AUG-2013, the patient experienced throat hoarseness during the late afternoon which became worse in the evening of 21-AUG-2013. No treatment was reported (also reported as no treatment was given to the event). Patient did not seek medical attention. The outcome of throat hoarseness was reported as not recovered/not resolved. Additional information has been requested.
Diarrhea began the evening of the 21st of Dec and lasted through the 30th of Dec 2012. Also she got a fever of 104 beginning 12/24/2012 at 4:00 PM that lasted through 12/25/2012 around 5:00 PM. No other symptoms.
Breakthrough COVID case: The symptoms started around 06:00PM on Wednesday, May 18th. They started with congestion and sneezing. I went to bed after taking an Alka-Seltzer night time, one tablet. When I woke up in the morning of the 19th, I was achy and congested. I was scheduled to work that day, but my husband suggested I take a COVID test before leaving for work. Taking the COVID test, my result showed positive within 5 minutes at the most. I called in sick and looked for a place that carried antivirals. I made an appointment at the clinic for 05:00PM. I took the antivirals around 06:00PM. I'm still feeling pretty congested. It's been over a week now.
2:15 pm.  Complained of dizziness, blurred vision and diaphoresis.  Stated he has prior fear of needles.  2:20 VS 95/65; p79; Sat 97. R. 14. Offered water, cereal bar. Stated he felt better. Assessed by NP and onsite EMS. Remained in Observation for 30 minutes. Discharged home 2:50 pm. All symptoms resolved.
Slight swelling of upper left arm. Slight redness 2x3 inches at injection site. Slight continued discomfort upon palpating at injection site.
Patient complained of arm pain, hot, and light headed. Patients eyes then rolled back and she became unresponsive for 10 seconds. EMS was called, patient had normal exam and mentation status after the event.
Pt developed a left parietal headache - that returns daily - treated with ADVIL - neuro exam - normal.
patient had flu; cough; patient doesnot feel well; patient had lot of body aches; headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (patient had flu), COUGH (cough), FEELING ABNORMAL (patient doesnot feel well), MYALGIA (patient had lot of body aches) and HEADACHE (headache) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus, Fibromyalgia, Arthritis and Depression.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, the patient experienced INFLUENZA (patient had flu), COUGH (cough), FEELING ABNORMAL (patient doesnot feel well), MYALGIA (patient had lot of body aches) and HEADACHE (headache). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at a dose of 1 dosage form. At the time of the report, INFLUENZA (patient had flu), COUGH (cough), FEELING ABNORMAL (patient doesnot feel well), MYALGIA (patient had lot of body aches) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications include Diabetes Type 2 medication, Arthritis medication, Fibromyalgia medication and antidepressants.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: TCR received on 07 Jun 2021 and patient ethnicity was updated and adverse event onset date changed
Went to hospital did MRI scan, IV left arm had clots. Next day chest pain, 2 clots, following week breathing issues and double pulmonary embolism.
bells type palsy noted on lt side of face;devel w/in 12-18hr p/vax;DPH given w/no effect;MD currently tx w/pred;
Felt fatigued and feverish 24 hours after vaccination, then on Saturday night (about 30 hours after the shot) noticed sore throat and swollen lymph nodes on left side of neck and on left armpit
Pt. c/o feeling faint & flushed 5 min after Hep B injection to L deltoid area.  Pulse & BP checked q 5 min x 30 min; pt sat near open window to cool down.  2nd Hep B in series of 3.
I can't even lift my arm. It is completely useless. It is so painful if I move it at all. I have had plenty of vaccines and never had a reaction like this.
Red rash and soreness on the left arm, chills and tired,  Went away after a couple of days rash and big red circle and puffy on arm  came back on 1/28/21 and has not gone away.
Soreness in her underarm/started having pain under her arm; Soreness at the injection site/arm was so sore that she could not move it; Fever; Chills; This spontaneous case was reported by a pharmacist and describes the occurrence of AXILLARY PAIN (Soreness in her underarm/started having pain under her arm), INJECTION SITE PAIN (Soreness at the injection site/arm was so sore that she could not move it), PYREXIA (Fever) and CHILLS (Chills) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039420A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Dec-2020, the patient experienced INJECTION SITE PAIN (Soreness at the injection site/arm was so sore that she could not move it), PYREXIA (Fever) and CHILLS (Chills). On 29-Dec-2020, the patient experienced AXILLARY PAIN (Soreness in her underarm/started having pain under her arm). The patient was treated with ACETAMINOPHEN 500 mg BID-TID and IBUPROFEN 200 mg at an unspecified frequency. On 26-Dec-2020, INJECTION SITE PAIN (Soreness at the injection site/arm was so sore that she could not move it), PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, AXILLARY PAIN (Soreness in her underarm/started having pain under her arm) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, C-reactive protein increased: ELEVATED. On an unknown date, Pneumocystis jirovecii pneumonia: normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jan-2021: Injection site, new events of fever and chills; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
was vaccinated with the COVID-19 vaccine and booster that positive for COVID-19; was vaccinated with the COVID-19 vaccine and booster that positive for COVID-19; This is a spontaneous report received from a contactable reporter(s) (Pharmacist), Program ID.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "was vaccinated with the COVID-19 vaccine and booster that positive for COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Warm transfer from agent withheld Paxlovid Call Center IVR CEP has a healthcare professional who has a patient that was vaccinated with the COVID-19 vaccine and booster that positive for COVID-19. Is using Paxlovid. Asked if there is a time interval to get the second booster shot of COVID-19 vaccine after completing the dose of Paxlovid. Information confirmed as provided. Wanted to know if there was a suggested time of completion after Paxlovid with no symptoms. Wanted to know if it is 30 or 90 days or has it been established yet. Description of Product Complaint: Description of complaint: PC#1: COVID-19 vaccine: Is positive for COVID-19. PC#2: COVID-19 vaccine (booster): Is positive for COVID-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information in the case, an association between the reported events and the suspect product BNT162B2 cannot be ruled out.
Roughly a 3 1/2 diameter swelling and redness around site of injection. Symptoms appeared/noticed about 1 1/2 days after injection. ZYRTEC 10mg and Hydrocortisone 1% cream was given for tx.
Patient experienced dizziness after vaccination which subsided shortly after. She also experienced fatigue and pain in muscle and joint on both upper and lower limbs. Muscle and joint pain is slowly easing  down since the vaccination date. Patient also reported she had diarrhea and tissue pain.
Hives, itchiness, redness all over body that has lasted for over a week.
Information has been received on 11-SEP-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. In 2014, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route at a pharmacy as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster or shingles. In 2016, the patient was treated by an acute nurse practitioner at a family medicine for a blistering vesicular outbreak, which was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX and/or despite receiving the ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
Red, swollen, and itchy around injection site on arm.  Patient describes area of inflammation as a welt and to be 5" long and 3" wide.  Patient called MD and MD instructed her to take Benadryl, in which she has been doing.